Financial Daily from THE HINDU group of publications
Saturday, April 02, 2005

Markets (April 01)
BL 2502118.25 (+34.80)
BSE Sensex6605.04(+112.22)
S&P CNX Nifty2067.65 (+32.00)
Gold Std(10 gm) 6130 (-45)
If you have any queries or need any clarifications, ask our experts...
SEARCH
BUSINESS LINE
USING GOOGLE
 
02/04/2005 Back to Financial News
Ranbaxy gets USFDA nod for capsules to treat urinary infection

Our Bureau

New Delhi , April 1

RANBAXY Laboratories Ltd has received approval from the US Food and Drug Administration (USFDA) to manufacture and market Nitrofurantoin Monohydrate/Macrocrystals capsules, 100 mg used for the treatment of urinary infection.

The Ranbaxy formulation is bioequivalent and has the same therapeutic effect as Proctor and Gamble Pharmaceuticals Inc's Macrobid.

The total annual market sales for Nitrofurantoin Monohydrate/Macrocrystals capsules last year were $80 million.

02/04/2005 Back to Financial News
CitiNRI | Resources Home | Financial News | Tax & Legal | RBI | Real Estate | Get the expert opinion | Archives | FAQ

Copyright © 2005, The Hindu Business Line.
Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line.